Published in Blood Weekly, January 19th, 2006
According to a report from Italy, "Since 1990 our group has been using extracorporeal circulation to ozonate blood by an original method, known as extracorporeal blood oxygenation and ozonation (EBOO), with the aim of amplifying the results observed with ozone autohemotherapy. The objective is to verify the hypothesis that EBOO improves the skin lesions typical of peripheral artery disease (PAD) patients."
N. di Paolo and colleagues at the University...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.